CXCR4 antagonist
Motixafortide companies
Answer
Public registers name 1 bulk ingredient labeler, 2 US labelers and 7 trial sponsors for Motixafortide.
Each row is what a register states. A company named here is not endorsed or accused by this site.
BULK INGREDIENT LABELER
1 company
Lists the bulk active ingredient with FDA (NDC directory).
| Polypeptide Laboratories San Diego, LLC | MOTIXAFORTIDE, BULK INGREDIENT Regulator openFDA |
|---|
US LABELER
2 companies
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| BioLineRx USA Inc | Aphexda, NDA Regulator openFDA |
|---|---|
| Gamida Cell Inc. | APHEXDA, NDA Regulator openFDA |
TRIAL SPONSOR
7 companies
Sponsors registered clinical trials of the peptide.
| Washington University School of Medicine | 3 registered trials Trial register ClinicalTrials.gov |
|---|---|
| St. Jude Children's Research Hospital | 2 registered trials Trial register ClinicalTrials.gov |
| Bioline Rx Ltd. | 1 registered trial Trial register EU CTIS |
| BioLineRx, Ltd. | 1 registered trial Trial register ClinicalTrials.gov |
| Columbia University | 1 registered trial Trial register ClinicalTrials.gov |
| Emory University | 1 registered trial Trial register ClinicalTrials.gov |
| Guangzhou Gloria Biosciences Co., Ltd. | 1 registered trial Trial register ClinicalTrials.gov |
Every company across all peptides: companies. Names are matched only when identical apart from case and punctuation, so one group can appear under two spellings.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.